PLEURAL MESOTHELIOMA
Clinical trials for PLEURAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new PLEURAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug XmAb20717 tested in rare cancers – trial suspended
Disease control TerminatedThis phase II trial tests the safety and effectiveness of a drug called XmAb20717 in 140 people with advanced rare cancers, including mesothelioma, lymphoma, and small cell lung cancer. The drug is given by IV. The main goal is to see if tumors shrink. The trial is currently susp…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New combo therapy shows promise for rare lung cancer
Disease control OngoingThis study tests whether giving a combination of the immunotherapy drug pembrolizumab and chemotherapy before surgery can help people with a rare cancer called pleural mesothelioma. The trial involves 41 adults with early-stage disease that can be surgically removed. The main goa…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Radiation and immunotherapy join forces against mesothelioma
Disease control OngoingThis early-phase trial is testing whether combining a precise type of radiation (SBRT) with immunotherapy can safely treat pleural mesothelioma, a rare cancer of the lung lining. About 20 adults with confirmed mesothelioma will receive both treatments. The main goal is to see if …
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC